Cargando…
Feasibility Analysis of Interleukin-13 as a Target for a Therapeutic Vaccine
Background: The development of therapeutic vaccines requires thorough knowledge of potential hazards associated with long-term inactivation of self-proteins. Among potential targets, interleukin 13 (IL-13) merits consideration, as monoclonal antibodies disrupting IL-13 signaling are proving to be ex...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466196/ https://www.ncbi.nlm.nih.gov/pubmed/30759882 http://dx.doi.org/10.3390/vaccines7010020 |